United States ex rel. Merena v. SmithKline Beecham Corp.
Court of Appeals for the Third Circuit
1Opinion of the Court
OPINION OF THE COURT
ALITO, Circuit Judge:
In this appeal, the United States challenges the District Court’s decision to award a group of qui tam relators approximately $52 million of the government’s settlement with defendant SmithKline Beecham Clinical Laboratories of a variety of claims under the False Claims Act, 31 U.S.C. § 3729 et seq. For the reasons explained below, we reverse and remand for further proceedings.
I
A. In 1992, the United States began to suspect that SmithKline Beecham Clinical Laboratories (“SKB”) and several other medical laboratories had adopted the following scheme that…
2Cases cited8 opinions
- United States ex rel. LaCorte v. SmithKline Beecham Clinical Laboratories, Inc.Court of Appeals for the Third Circuit · 1998
- United States v. HOUSING AUTHORITY OF THE CITY OF PITTSBURGHCourt of Appeals for the Third Circuit · 1999
- Federal Recovery Services, Inc. v. United StatesCourt of Appeals for the Fifth Circuit · 1995
- United States of America Ex Rel. John Fallon v. Accudyne Corporation and Alliant Techsystems, Inc.Court of Appeals for the Seventh Circuit · 1996
- United States ex rel. Bayarsky v. BrooksCourt of Appeals for the Tenth Circuit · 1946
3 more not listed; retrieve them via the Exa API.
3Cited by44 opinions
- Rockwell International Corp. v. United StatesSupreme Court of the United States · 2007
- United States Ex Rel. Schumann v. Astrazeneca Pharmaceuticals L.P.Court of Appeals for the Third Circuit · 2014
- United States Ex Rel. Hockett v. Columbia/HCA Healthcare Corp.District Court, District of Columbia · 2007
- United States Ex Rel. Boothe v. Sun Healthcare Group, Inc.Court of Appeals for the Tenth Circuit · 2007
- McGuire v. Estate of Robert CunninghamCourt of Appeals for the First Circuit · 2019
39 more not listed; retrieve them via the Exa API.